Skip to playerSkip to main content
  • 2 minutes ago
A study of more than 26,000 men from 11 long-running studies, led by the University of Western Australia and published in Lancet Healthy Longevity, links very low testosterone to an 18% higher risk of dying from cancer. Risk began rising when testosterone fell below 8.6 nanomoles per liter. Natural testosterone levels were not linked to prostate cancer, which tracked instead with low levels of two other hormones. The researchers stress the finding is an association and does not support taking testosterone to prevent cancer.

Category

🗞
News
Transcript
00:00A simple blood test might one day offer an early clue about cancer risk in men.
00:04A large study led by the University of Western Australia looked at testosterone.
00:09Researchers pooled data from more than 26,000 men across 11 long-running studies.
00:14Blood samples were taken years earlier, then matched with health records over decades.
00:19Men in the lowest fifth for testosterone had an 18% higher risk of dying from cancer.
00:25That held even after accounting for age and other health factors.
00:28Risks started rising when testosterone dropped below 8.6 nanomoles per liter.
00:34Natural testosterone levels were not linked to prostate cancer at all.
00:39Instead, prostate cancer tracked with low levels of two other hormones.
00:43The study appears in Lancet Healthy Longevity.
00:46The researchers stress it shows a link, not proof of cause.
00:49And there's no evidence that testosterone supplements lower cancer risk.
00:54Disclosure.
00:54This video contains stock footage and content created or enhanced using AI-assisted tools.
Comments

Recommended